Subscribe to Pharmaceutical Processing News

The Lead

Chemical Industry Group Launches Defense of BPA

March 3, 2015 | by Andy Szal, Digital Reporter | Comments

The American Chemistry Council announced an ad campaign highlighting recent evaluations of bisphenol A as "safe." The ads--running in USA Today, the Wall Street Journal and on consumer, news and health websites--urge readers to "listen to the science" on BPA, a synthetic compound found in many plastics and resins.


Johnson & Johnson Innovation Announces New Startup Campus

March 3, 2015 2:17 pm | by Andy Szal, Digital Reporter | Comments

The venture capital arm of the New Jersey consumer products giant officially unveiled its JLABS@South San Francisco campus Monday. The 30,000-square foot incubator will eventually house up to 50 startups.


Blueprint Medicines Announces $265M Strategic Collaboration with Alexion

March 3, 2015 1:48 pm | Comments

Blueprint Medicines has announced a strategic collaboration with Alexion to discover, develop and commercialize novel drug candidates for an undisclosed activated kinase target, which is the cause of a rare genetic disease.


Health Officials Perplexed by Vaccination Skeptics

March 3, 2015 1:32 pm | by MIKE STOBBE, AP Medical Writer | Comments

Certain that they are right, struggling to find ways to get their message across, public health officials are exasperated by their inability to convince more U.S. parents to vaccinate their children.


Merz North America Appoints Vice President, Chief Compliance Officer

March 3, 2015 11:44 am | Comments

Merz North America has announced the appointment of Salisa Hauptmann as Vice President and Chief Compliance Officer. Hauptmann will be responsible for providing strategic and operational leadership to Merz on matters relating to compliance issues, including industry standards established by the Department of Health and Human Services, the Office of Inspector General, and other Federal and state agencies.


Photo of the Day: Native Americans and Medical Marijuana

March 3, 2015 11:35 am | by Mike Auerbach, Editor-In-Chief | Comments

Audience members look on at a tribal marijuana conference for tribal governments considering whether to legalize marijuana for medicinal, agricultural, or recreational use.


Report: As Ebola Wanes, Other Countries Remain Vulnerable

March 3, 2015 9:37 am | by KRISTA LARSON, Associated Press | Comments

Arriving airline passengers lined up outdoors to have their temperatures checked, the screens in the nighttime darkness like glowing lightning bugs. Some of the travelers checked by workers with surgical masks had traveled through a West African country affected by Ebola, or sat next to passengers who did, and Chadian authorities weren't taking any chances.


Explained: Supreme Court Case Against Obama's Health Law

March 3, 2015 9:16 am | by ALEXANDRA OLSON, Associated Press | Comments

he U.S. Supreme Court this week hears a challenge to President Barack Obama's health care overhaul. If successful, the lawsuit would cripple Obama's prized domestic achievement, a program that has brought the U.S. as close as it has ever come to universal health care.


Sun Pharma to Buy GSK’s Opiates Business in Australia

March 3, 2015 9:05 am | Comments

The current GSK Opiates business including related manufacturing sites in Latrobe (Tasmania) and Port Fairy (Victoria) and its portfolio of opiates products along with inventory, will transfer to a subsidiary of Sun Pharma.


Pfizer Receives European Approval for New Indication for Prevenar 13

March 3, 2015 8:47 am | Comments

Pfizer has announced that the European Commission approved an expanded indication for the use of Prevenar 13 for the prevention of pneumonia caused by the 13 pneumococcal serotypes in the vaccine in adults aged 18 years and older.


Nurse Who Survived Ebola Sues Dallas Hospital System

March 3, 2015 8:18 am | by JAMIE STENGLE, Associated Press | Comments

The Dallas hospital that treated the first patient to be diagnosed in the U.S. with Ebola lied to Congress when it said its staff was trained to handle the deadly virus, a nurse who contracted the disease contends in a lawsuit filed Monday.


AstraZeneca Completes Acquisition of Actavis’ Respiratory Products

March 3, 2015 8:05 am | Comments

AstraZeneca today announced that it has completed the transaction to acquire the rights to Actavis’ branded respiratory business in the US and Canada.


Pacira Pharma Slumps after FDA Ruling on Pain Drug

March 3, 2015 8:01 am | Comments

Shares of Pacira Pharmaceuticals tumbled Monday after the company said regulators refused to grant a new marketing approval for its post-surgical pain drug Exparel.


Report: High Number of Potential Alzheimer's Drugs In Development

March 3, 2015 7:54 am | by Andy Szal, Digital Reporter | Comments

According to an analysis by New York-based GBI Research, Alzheimer’s drugs in development since 2006 failed at a 95 percent rate across all three phases of pharmaceutical development, much higher than the industry average.


UN Warns Against Complacency as Ebola Fight Enters New Phase

March 2, 2015 3:56 pm | by LORNE COOK, Associated Press | Comments

The United Nations is urging donors, organizations and countries fighting Ebola in West Africa not to give in to complacency as the death toll from the virus climbs toward 10,000.


GSK Completes Transaction with Novartis

March 2, 2015 3:48 pm | Comments

Britain's GlaxoSmithKline PLC and Switzerland's Novartis AG have completed a three-part deal that will offer the British company's shareholders a 4 billion pound ($6.17 billion) windfall.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.